A field guide to BPC-157The criteria
PRODUCT / CARE / COMMITMENT
Open the provider file

Research explained

BPC-157 and duodenal injury after vein ligation

A specialized surgical vascular model is not evidence for routine gut symptoms or human treatment.

On this page

Read the experiment

The finding and its boundary

The authors reported reduced lesions and recruitment of alternative venous flow. A specialized surgical vascular model is not evidence for routine gut symptoms or human treatment.

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine.

Experiment
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Study system
Male rats with superior anterior pancreaticoduodenal vein ligation
Measured outcome
Vessel presentation, mucosal injury, congestion and oxidative markers
Reported result
The authors reported reduced lesions and recruitment of alternative venous flow.
What this cannot establish
A specialized surgical vascular model is not evidence for routine gut symptoms or human treatment.
Open the primary paper

What was actually tested

Male rats with superior anterior pancreaticoduodenal vein ligation. The investigators measured vessel presentation, mucosal injury, congestion and oxidative markers. The authors reported reduced lesions and recruitment of alternative venous flow.

The detail that changes the takeaway

The duodenal lesion followed a defined drainage problem. Its cause is not the same as diet-related discomfort or inflammatory bowel disease. The collateral route identifies a mechanistic hypothesis, while the lesion measurements identify what improved; neither establishes a general digestive indication.

How far the result travels

A specialized surgical vascular model is not evidence for routine gut symptoms or human treatment.

A useful comparison

BPC-157 in a rat hepatic-outflow obstruction model examines collateral pathways, pressures, organ injury and biochemical markers. Here, the measured endpoint was vessel presentation, mucosal injury, congestion and oxidative markers. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the BPC-157 after bowel resection in rats: adaptation is a specific research question appraisal.

References & product documents

The evidence and service information used here.

  1. BPC-157 and duodenal injury after vein ligation — original indexed research

Next in the field guide

The provider file
  1. 01

    BPC-157 after bowel resection in rats: adaptation is a specific research question

    The 2009 experiment followed intestinal changes after major surgery. It does not establish treatment of short bowel syndrome in people or a general gut-health benefit.

  2. 02

    BPC-157 in a rat hepatic-outflow obstruction model

    The experimental obstruction does not establish therapy for human Budd–Chiari syndrome.

  3. 03

    BPC-157 after sagittal-sinus ligation in rats

    A ligation model is not evidence of safe treatment for a person's cerebral venous thrombosis.

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review